Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1982 Nov;38(2):502–512. doi: 10.1128/iai.38.2.502-512.1982

Effects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cells.

T J Sims, R C Page
PMCID: PMC347767  PMID: 6128306

Abstract

The degree of responsiveness of lymphoid cells to activation by mitogens and antigens is commonly assessed in vitro by measuring radioactive DNA precursor incorporation. Several lines of evidence indicate that artifacts affect the results and that these measurements may not be an accurate reflection of cell activation. Cultures of blastogenically activated lymphocytes contain soluble, noncytotoxic factors that inhibit the incorporation of radioactive nucleosides into DNA by dividing cells without affecting their rate of DNA synthesis. Inhibitors were found in the serum component of the medium and in the bacterial homogenates used to activate the cells, and they were produced by the activated cells. Inhibitor activity in serum has properties expected of a nucleoside such as thymidine, including a molecular weight of less than 10(3). The inhibitor activity present in some bacterial homogenates and that produced by activated cells enzymically degrade labeled DNA precursors, thereby preventing their availability for incorporation. Other bacterial preparations contain DNA precursors, which compete with labeled nucleosides for incorporation, and additional low-molecular-weight inhibitor is produced when the preparations are incubated. Preparations of various bacteria differ greatly with regard to the potency of their inhibitor activity. In some cases incorporation of label in activated cultures is reduced to background levels. Inhibition by these substances leads to erroneous conclusions regarding the proliferative activity of cultured lymphocytes, since the amount of label incorporated does not accurately indicate the true rate of DNA synthesis of the cells.

Full text

PDF
502

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asantila T., Toivanen P. Potentation by fluorodeoxyuridine of 125I-deoxyuridine uptake by human and chicken lymphocytes in the quantitation of mitogenic response. J Immunol Methods. 1974 Dec;6(1-2):73–82. doi: 10.1016/0022-1759(74)90091-x. [DOI] [PubMed] [Google Scholar]
  2. Bain B. Tritiated-thymidine uptake in mixed leucocyte cultures: effect of specific activity and exposure time. Clin Exp Immunol. 1970 Feb;6(2):255–262. [PMC free article] [PubMed] [Google Scholar]
  3. Baker J. J., Chan S. P., Socransky S. S., Oppenheim J. J., Mergenhagen S. E. Importance of Actinomyces and certain gram-negative anaerobic organisms in the transformation of lymphocytes from patients with periodontal disease. Infect Immun. 1976 May;13(5):1363–1368. doi: 10.1128/iai.13.5.1363-1368.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COOPER E. H., MILTON J. D. THE INCORPORATION AND DEGRADATION OF PYRIMIDINE DNA PRECURSORS BY HUMAN LEUCOCYTES. Br J Cancer. 1964 Dec;18:701–713. doi: 10.1038/bjc.1964.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Engel D., Epps D. V., Clagett J. In vivo and in vitro studies on possible pathogenic mechanisms of Actinomyces viscosus. Infect Immun. 1976 Aug;14(2):548–554. doi: 10.1128/iai.14.2.548-554.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Evans R., Booth C. G. Inhibition of 125IUdR incorporation by supernatants from macrophage and lymphocyte cultures: a cautionary note. Cell Immunol. 1976 Sep;26(1):120–126. doi: 10.1016/0008-8749(76)90354-3. [DOI] [PubMed] [Google Scholar]
  7. Fink K., Adams W. S. Paper chromatographic data for purines, pyrimidines and derivatives in a variety of solvents. J Chromatogr. 1966 Apr;22(1):118–129. doi: 10.1016/s0021-9673(01)97077-3. [DOI] [PubMed] [Google Scholar]
  8. Goodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977 Dec 1;146(6):1719–1734. doi: 10.1084/jem.146.6.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  10. Horton J. E., Leikin S., Oppenheim J. J. Human lymphoproliferative reaction to saliva and dental plaque-deposits: an in vitro correlation with periodontal disease. J Periodontol. 1972 Sep;43(9):522–527. doi: 10.1902/jop.1972.43.9.522. [DOI] [PubMed] [Google Scholar]
  11. Horton J. E., Oppenheim J. J., Mergenhagen S. E. Elaboration of lymphotoxin by cultured human peripheral blood leucocytes stimulated with dental-plaque deposits. Clin Exp Immunol. 1973 Mar;13(3):383–393. [PMC free article] [PubMed] [Google Scholar]
  12. Hughes W. L., Christine M., Stollar D. A radioimmunoassay for measurement of serum thymidine. Anal Biochem. 1973 Oct;55(2):468–478. doi: 10.1016/0003-2697(73)90137-1. [DOI] [PubMed] [Google Scholar]
  13. Ivanyi L., Lehner T. Lymphocyte transformation by sonicates of dental plaque in human periodontal disease. Arch Oral Biol. 1971 Sep;16(9):1117–1121. doi: 10.1016/0003-9969(71)90216-0. [DOI] [PubMed] [Google Scholar]
  14. Ivanyi L., Lehner T. Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease. Arch Oral Biol. 1970 Nov;15(11):1089–1096. doi: 10.1016/0003-9969(70)90121-4. [DOI] [PubMed] [Google Scholar]
  15. Janossy G., Greaves M. F., Doenhoff M. J., Snajdr J. Lymphocyte activation. V. Quantitation of the proliferative responses to mitogens using defined T and B cell populations. Clin Exp Immunol. 1973 Aug;14(4):581–596. [PMC free article] [PubMed] [Google Scholar]
  16. Kasahara T., Shiori-Nakano K. Splenic suppressing factor: purification and characterization of a factor suppressing thymidine incorporation into activated lymphocytes. J Immunol. 1976 May;116(5):1251–1256. [PubMed] [Google Scholar]
  17. Lang N. P., Smith F. N. Lymphocyte blastogenesis to plaque antigens in human periodontal disease. I. Populations of varying severity of disease. J Periodontal Res. 1977 Jul;12(4):298–309. doi: 10.1111/j.1600-0765.1977.tb00134.x. [DOI] [PubMed] [Google Scholar]
  18. Lang N. P., Smith F. N. Lymphocyte response to T-cell mitogen during experimental gingivitis in humans. Infect Immun. 1976 Jan;13(1):108–113. doi: 10.1128/iai.13.1.108-113.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. MARSH J. C., PERRY S. THYMIDINE CATABOLISM BY NORMAL AND LEUKEMIC HUMAN LEUKOCYTES. J Clin Invest. 1964 Feb;43:267–278. doi: 10.1172/JCI104911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mackler B. F., Altman L. C., Wahl S., Rosenstreich D. L., Oppenheim J. J., Mergenhagen S. E. Blastogenesis and lymphokine synthesis by T and B lymphocytes from patients with periodontal disease. Infect Immun. 1974 Oct;10(4):844–850. doi: 10.1128/iai.10.4.844-850.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Menconi E., Neri M., Sorci V., Frati L. The use of [125I]deoxyuridine for semi-microevaluation of human lymphocyte response to phytohemagglutinin in vitro. J Immunol Methods. 1978;22(1-2):191–196. doi: 10.1016/0022-1759(78)90071-6. [DOI] [PubMed] [Google Scholar]
  22. Milton J. D., Cooper E. H., Halle-Pannenko O. DLa dégradation de la thymidine par les lymphocytes transformés. Rev Fr Etud Clin Biol. 1965 Apr;10(4):419–422. [PubMed] [Google Scholar]
  23. Nykänen P. J. Degradation of thymidine to thymine by rheumatoid arthritis synovial tissue eluate. Scand J Immunol. 1979;9(5):477–482. doi: 10.1111/j.1365-3083.1979.tb03070.x. [DOI] [PubMed] [Google Scholar]
  24. Opitz H. G., Niethammer D., Jackson R. C., Lemke H., Huget R., Flad H. D. Biochemical characterization of a factor released by macrophages. Cell Immunol. 1975 Jul;18(1):70–75. doi: 10.1016/0008-8749(75)90037-4. [DOI] [PubMed] [Google Scholar]
  25. Page R. C., Clagett J. A., Engel L. D., Wilde G., Sims T. Effects of prostaglandin on the antigen- and mitogen-driven responses of peripheral blood lymphocytes from patients with adult and juvenile periodontitis. Clin Immunol Immunopathol. 1978 Sep;11(1):77–87. doi: 10.1016/0090-1229(78)90205-2. [DOI] [PubMed] [Google Scholar]
  26. Patters M. R., Genco R. J., Reed M. J., Mashimo P. A. Blastogenic response of human lymphocytes to oral bacterial antigens: comparison of individuals with periodontal disease to normal and edentulous subjects. Infect Immun. 1976 Nov;14(5):1213–1220. doi: 10.1128/iai.14.5.1213-1220.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Patters M. R., Sedransk N., Genco R. J. Lymphoproliferative response during resolution and recurrence of naturally occurring gingivitis. J Periodontol. 1977 Jul;48(7):373–380. doi: 10.1902/jop.1977.48.7.373. [DOI] [PubMed] [Google Scholar]
  28. Peter H. H., Feldman J. D. Cell-mediated cytotoxicity during rejection and enhancement of allogeneic skin grafts in rats. J Exp Med. 1972 Jun 1;135(6):1301–1315. doi: 10.1084/jem.135.6.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. RACHMELER M., GERHART J., ROSNER J. Limited thymidine uptake in Escherichia coli due to an inducible thymidine phosphorylase. Biochim Biophys Acta. 1961 Apr 29;49:222–225. doi: 10.1016/0006-3002(61)90888-5. [DOI] [PubMed] [Google Scholar]
  30. Reed M. J., Neiders M. E., Genco R. J. Synergistic effects on DNA synthesis in peripheral blood lymphocytes of mitogens and dental plaque sonicates in man and macaque monkeys. Arch Oral Biol. 1976;21(7):441–445. doi: 10.1016/0003-9969(76)90009-1. [DOI] [PubMed] [Google Scholar]
  31. Reed M. J., Patters M. R., Mashimo P. A., Genco R. J., Levine R. J. Blastogenic response of human lymphocytes to oral bacterial antigens: characterization of bacterial sonicates. Infect Immun. 1976 Nov;14(5):1202–1212. doi: 10.1128/iai.14.5.1202-1212.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sample W. F., Chretien P. B. Thymidine kinetics in human lymphocyte transformation: determination of optimal labelling conditions. Clin Exp Immunol. 1971 Sep;9(3):419–427. [PMC free article] [PubMed] [Google Scholar]
  33. Schellekens P. T., Eijsvoogel V. P. Lymphocyte transformation in vitro. I. Tissue culture conditions and quantitative measurements. Clin Exp Immunol. 1968 Jul;3(6):571–584. [PMC free article] [PubMed] [Google Scholar]
  34. Schneider W., Doenecke C., Scheurlen P. G. Detection of thymidine-phosphorylase in human blood platelets. Klin Wochenschr. 1973 Mar 15;51(6):287–288. doi: 10.1007/BF01467820. [DOI] [PubMed] [Google Scholar]
  35. Sims T., Clagett J. A., Page R. C. Effects of cell concentration and exogenous prostaglandin on the interaction and responsiveness of human peripheral blood leukocytes. Clin Immunol Immunopathol. 1979 Feb;12(2):150–161. doi: 10.1016/0090-1229(79)90004-7. [DOI] [PubMed] [Google Scholar]
  36. Smith F. N., Lang N. P. Lymphocyte blastogenesis to plaque antigens in human periodontal disease. ii. The relationship to clinical parameters. J Periodontal Res. 1977 Jul;12(4):310–317. doi: 10.1111/j.1600-0765.1977.tb00135.x. [DOI] [PubMed] [Google Scholar]
  37. Stadecker M. J., Calderon J., Karnovsky M. L., Unanue E. R. Synthesis and release of thymidine by macrophages. J Immunol. 1977 Nov;119(5):1738–1743. [PubMed] [Google Scholar]
  38. Twomey J. J., Laughter A. H., Farrow S., Douglass C. C. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest. 1975 Aug;56(2):467–475. doi: 10.1172/JCI108113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Usher D. C., Reiter H. Catabolism of thymidine during the lymphocyte cell cycle. Cell. 1977 Oct;12(2):365–370. doi: 10.1016/0092-8674(77)90112-x. [DOI] [PubMed] [Google Scholar]
  40. Yamamura M. Standardization of lymphocyte transformation to phytohaemagglutinin. Clin Exp Immunol. 1973 Jul;14(3):457–467. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES